BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12837294)

  • 21. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
    Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
    Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
    Chen X; Thakkar H; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK
    Oncogene; 2001 Sep; 20(42):6073-83. PubMed ID: 11593415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways.
    Janmaat ML; Kruyt FA; Rodriguez JA; Giaccone G
    Clin Cancer Res; 2003 Jun; 9(6):2316-26. PubMed ID: 12796401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways.
    Qiu Q; Yang M; Tsang BK; Gruslin A
    Reproduction; 2004 Sep; 128(3):355-63. PubMed ID: 15333786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calmodulin-mediated activation of Akt regulates survival of c-Myc-overexpressing mouse mammary carcinoma cells.
    Deb TB; Coticchia CM; Dickson RB
    J Biol Chem; 2004 Sep; 279(37):38903-11. PubMed ID: 15247222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxicity induced by manipulation of signal transduction pathways is associated with down-regulation of Bcl-2 but not Mcl-1 in MCF-7 human breast cancer.
    Hu Y; Dragowska WH; Wallis A; Duronio V; Mayer L
    Breast Cancer Res Treat; 2001 Nov; 70(1):11-20. PubMed ID: 11767000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells.
    Chaudhary LR; Hruska KA
    J Cell Biochem; 2001 Mar; 81(2):304-11. PubMed ID: 11241670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
    Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
    Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad.
    Shimamura H; Terada Y; Okado T; Tanaka H; Inoshita S; Sasaki S
    J Am Soc Nephrol; 2003 Jun; 14(6):1427-34. PubMed ID: 12761242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role for Bcl-xL in the regulation of apoptosis by EGF and TGF beta 1 in c-myc overexpressing mammary epithelial cells.
    Nass SJ; Li M; Amundadottir LT; Furth PA; Dickson RB
    Biochem Biophys Res Commun; 1996 Oct; 227(1):248-56. PubMed ID: 8858133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
    Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
    Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinctive regulation and function of PI 3K/Akt and MAPKs in doxorubicin-induced apoptosis of human lung adenocarcinoma cells.
    Zhao Y; You H; Yang Y; Wei L; Zhang X; Yao L; Fan D; Yu Q
    J Cell Biochem; 2004 Feb; 91(3):621-32. PubMed ID: 14755690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells.
    Hu H; Jiang C; Li G; Lü J
    Carcinogenesis; 2005 Aug; 26(8):1374-81. PubMed ID: 15845651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling associated with the induction of apoptosis.
    Marushige K; Marushige Y
    Anticancer Res; 1999; 19(5B):3865-71. PubMed ID: 10628325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II regulation of TGF-beta in murine mesangial cells involves both PI3 kinase and MAP kinase.
    Perlman A; Lawsin LM; Kolachana P; Saji M; Moore J; Ringel MD
    Ann Clin Lab Sci; 2004; 34(3):277-86. PubMed ID: 15487702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained Akt/PKB activation and transient attenuation of c-jun N-terminal kinase in the inhibition of apoptosis by IGF-1 in vascular smooth muscle cells.
    Allen RT; Krueger KD; Dhume A; Agrawal DK
    Apoptosis; 2005 May; 10(3):525-35. PubMed ID: 15909115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species.
    Rahmani M; Reese E; Dai Y; Bauer C; Payne SG; Dent P; Spiegel S; Grant S
    Cancer Res; 2005 Mar; 65(6):2422-32. PubMed ID: 15781658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT.
    Mirza AM; Gysin S; Malek N; Nakayama K; Roberts JM; McMahon M
    Mol Cell Biol; 2004 Dec; 24(24):10868-81. PubMed ID: 15572689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-methyl-D-aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal-regulated kinase pathway.
    Zhu D; Wu X; Strauss KI; Lipsky RH; Qureshi Z; Terhakopian A; Novelli A; Banaudha K; Marini AM
    J Neurosci Res; 2005 Apr; 80(1):104-13. PubMed ID: 15744743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivo.
    Karnauskas R; Niu Q; Talapatra S; Plas DR; Greene ME; Crispino JD; Rudin CM
    Oncogene; 2003 Feb; 22(5):688-98. PubMed ID: 12569361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.